NO20042879L - Piperidinylaminometyl-trifluormetyl cykliske eterforbindelser som substans P antagonister - Google Patents

Piperidinylaminometyl-trifluormetyl cykliske eterforbindelser som substans P antagonister

Info

Publication number: NO20042879L
Authority: NO; Norway
Prior art keywords: piperidinylaminomethyl; antagonists; substance; cyclic ether; ether compounds
Prior art date: 1997-11-19

Application number

NO20042879A

Other languages

English (en)

Inventor

Kunio Satake

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-19

Filing date

2004-07-07

Publication date

2000-07-17

2000-07-17 Publication of NO20042879L publication Critical patent/NO20042879L/no

2004-07-07 Application filed by Pfizer filed Critical Pfizer

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Otolaryngology (AREA)
Gynecology & Obstetrics (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)

NO20042879A 1997-11-19 2004-07-07 Piperidinylaminometyl-trifluormetyl cykliske eterforbindelser som substans P antagonister NO20042879L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IB9701466		1997-11-19
PCT/IB1998/001704 WO1999025714A1 (en)	1997-11-19	1998-10-26	Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists

Publications (1)

Publication Number	Publication Date
NO20042879L true NO20042879L (no)	2000-07-17

Family

ID=11004634

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20002544A NO20002544L (no)	1997-11-19	2000-05-18	Piperidinylaminometyl-trifluormetyl cykliske eterforbindelser som substans P antagonister
NO20042879A NO20042879L (no)	1997-11-19	2004-07-07	Piperidinylaminometyl-trifluormetyl cykliske eterforbindelser som substans P antagonister

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO20002544A NO20002544L (no)	1997-11-19	2000-05-18	Piperidinylaminometyl-trifluormetyl cykliske eterforbindelser som substans P antagonister

Country Status (39)

Country	Link
US (2)	US20030208079A1 (no)
EP (1)	EP1032571B1 (no)
JP (2)	JP3394239B2 (no)
KR (1)	KR100366902B1 (no)
CN (1)	CN1173974C (no)
AP (1)	AP909A (no)
AR (1)	AR016422A1 (no)
AT (1)	ATE219078T1 (no)
AU (1)	AU734218B2 (no)
BG (1)	BG63969B1 (no)
CA (1)	CA2310627C (no)
CO (1)	CO4771153A1 (no)
CZ (1)	CZ297315B6 (no)
DE (1)	DE69806045T2 (no)
DK (1)	DK1032571T3 (no)
DZ (1)	DZ2655A1 (no)
EA (1)	EA002621B1 (no)
ES (1)	ES2177058T3 (no)
HR (1)	HRP20000313B1 (no)
HU (1)	HUP0101112A3 (no)
ID (1)	ID24240A (no)
IL (1)	IL135631A0 (no)
IS (1)	IS2202B (no)
MA (1)	MA26567A1 (no)
MY (1)	MY120558A (no)
NO (2)	NO20002544L (no)
NZ (1)	NZ503912A (no)
OA (1)	OA11380A (no)
PA (1)	PA8463001A1 (no)
PE (1)	PE20000021A1 (no)
PL (1)	PL193484B1 (no)
PT (1)	PT1032571E (no)
RS (1)	RS49792B (no)
SK (1)	SK283460B6 (no)
TN (1)	TNSN98210A1 (no)
TR (1)	TR200001463T2 (no)
TW (1)	TW426667B (no)
UA (1)	UA59417C2 (no)
WO (1)	WO1999025714A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9812617D0 (en) *	1998-06-11	1998-08-12	Merck Sharp & Dohme	Therapeutic use
GB9812662D0 (en) *	1998-06-11	1998-08-12	Merck Sharp & Dohme	Therapeutic use
HRP20010821A2 (en) *	1999-05-06	2002-12-31	Pfizer Prod Inc	Substituted benzolactam compounds
RS49964B (sr)	1999-05-17	2008-09-29	Pfizer Products Inc.,	Postupak za dobijanje 2-fenil-3-aminopiridina,njegovih supstituisanih fenil derivata, i njegovih soli
EP1178984B1 (en) *	1999-05-21	2003-03-19	Pfizer Products Inc.	1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
WO2001025233A1 (en) *	1999-10-07	2001-04-12	Hisamitsu Pharmaceutical Co., Inc.	Piperidine derivatives
EP1095939B1 (en) *	1999-10-18	2004-01-07	Pfizer Products Inc.	Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
CA2324116A1 (en) *	1999-10-25	2001-04-25	Susan Beth Sobolov-Jaynes	Nk-1 receptor antagonists and eletriptan for the treatment of migraine
IL142810A0 (en) *	2000-05-03	2002-03-10	Pfizer Prod Inc	Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
US20020049211A1 (en) *	2000-09-06	2002-04-25	Sobolov-Jaynes Susan Beth	Combination treatment for depression and anxiety
EP1192952A3 (en) *	2000-09-28	2003-03-26	Pfizer Products Inc.	Combination, for treating depression and anxiety, containing an NK-3 receptor antagonist and a CNS penetrant NK-1 receptor antagonist
US6555581B1 (en)	2001-02-15	2003-04-29	Jones Pharma, Inc.	Levothyroxine compositions and methods
JP2004525109A (ja)	2001-02-15	2004-08-19	キング・ファーマシューティカルズ・インコーポレイティッド	安定化された甲状腺ホルモン医薬組成物、及びその製法
US7101569B2 (en)	2001-08-14	2006-09-05	Franz G Andrew	Methods of administering levothyroxine pharmaceutical compositions
ES2266416T3 (es)	2001-08-30	2007-03-01	Pfizer Products Inc.	Procedimiento para la preparacion de compuestos 2-(4-alquil-1-piperazinil)-benzaldehido y compuestos de -bencilidenilo por sustitucion nucleofila aromatica de 2-fluorobenzaldehido con 4-alquil-1-piperazina en agua como solvente.
US20040001895A1 (en) *	2002-06-17	2004-01-01	Pfizer Inc.	Combination treatment for depression and anxiety
CA2496447A1 (en) *	2002-08-27	2004-03-11	Mark L. Witten	Amelioration of effects of cigarette smoke
US6911544B2 (en) *	2002-10-23	2005-06-28	Pfizer Inc.	Process for the preparation of (S,S)-cis-2-phenyl-3-aminopiperidine
US7122700B2 (en)	2004-07-30	2006-10-17	Xerox Corporation	Arylamine processes
DE102008000891A1 (de)	2008-03-31	2009-10-01	Robert Bosch Gmbh	Schutzsystem für Werkzeugmaschinen
ES2672099T3 (es)	2011-07-04	2018-06-12	Irbm - Science Park S.P.A.	Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal
EP3758688B1 (en)	2018-02-26	2024-03-27	Ospedale San Raffaele S.r.l.	Nk-1 antagonists for use in the treatment of ocular pain
EP4117673A1 (en)	2020-03-11	2023-01-18	Ospedale San Raffaele S.r.l.	Treatment of stem cell deficiency

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9317987D0 (en) *	1993-08-26	1993-10-13	Glaxo Group Ltd	Chemical compounds
KR19980703354A (ko) *	1995-03-27	1998-10-15	나카토미히로타카	피페리딘 유도체
TW475930B (en) *	1995-04-24	2002-02-11	Novartis Ag	Novel compound, its use and pharmaceutical composition comprising it
JP3042894B2 (ja) *	1995-07-07	2000-05-22	ファイザー製薬株式会社	サブスタンスｐアンタゴニストとしての置換ベンゾラクタム化合物
TW340842B (en) *	1995-08-24	1998-09-21	Pfizer	Substituted benzylaminopiperidine compounds
US6329396B1 (en) *	1996-06-10	2001-12-11	Pfizer Inc.	Substituted benzylaminopiperidine compounds
EP1178984B1 (en) *	1999-05-21	2003-03-19	Pfizer Products Inc.	1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
EP1095939B1 (en) *	1999-10-18	2004-01-07	Pfizer Products Inc.	Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds

1998
- 1998-10-21 TW TW087117444A patent/TW426667B/zh not_active IP Right Cessation
- 1998-10-26 IL IL13563198A patent/IL135631A0/xx not_active IP Right Cessation
- 1998-10-26 DK DK98947726T patent/DK1032571T3/da active
- 1998-10-26 WO PCT/IB1998/001704 patent/WO1999025714A1/en not_active Ceased
- 1998-10-26 HU HU0101112A patent/HUP0101112A3/hu unknown
- 1998-10-26 CZ CZ20001834A patent/CZ297315B6/cs not_active IP Right Cessation
- 1998-10-26 AU AU94549/98A patent/AU734218B2/en not_active Ceased
- 1998-10-26 HR HR960576A patent/HRP20000313B1/xx not_active IP Right Cessation
- 1998-10-26 RS YUP-294/00A patent/RS49792B/sr unknown
- 1998-10-26 NZ NZ503912A patent/NZ503912A/xx unknown
- 1998-10-26 EP EP98947726A patent/EP1032571B1/en not_active Expired - Lifetime
- 1998-10-26 TR TR2000/01463T patent/TR200001463T2/xx unknown
- 1998-10-26 ID IDW20000926A patent/ID24240A/id unknown
- 1998-10-26 ES ES98947726T patent/ES2177058T3/es not_active Expired - Lifetime
- 1998-10-26 CN CNB988112930A patent/CN1173974C/zh not_active Expired - Fee Related
- 1998-10-26 UA UA2000042374A patent/UA59417C2/uk unknown
- 1998-10-26 EA EA200000432A patent/EA002621B1/ru not_active IP Right Cessation
- 1998-10-26 JP JP2000521096A patent/JP3394239B2/ja not_active Expired - Fee Related
- 1998-10-26 PT PT98947726T patent/PT1032571E/pt unknown
- 1998-10-26 DE DE69806045T patent/DE69806045T2/de not_active Expired - Fee Related
- 1998-10-26 SK SK723-2000A patent/SK283460B6/sk unknown
- 1998-10-26 AT AT98947726T patent/ATE219078T1/de not_active IP Right Cessation
- 1998-10-26 CA CA002310627A patent/CA2310627C/en not_active Expired - Fee Related
- 1998-11-11 PA PA19988463001A patent/PA8463001A1/es unknown
- 1998-11-16 PE PE1998001112A patent/PE20000021A1/es not_active Application Discontinuation
- 1998-11-17 MY MYPI98005209A patent/MY120558A/en unknown
- 1998-11-17 MA MA25354A patent/MA26567A1/fr unknown
- 1998-11-17 AR ARP980105829A patent/AR016422A1/es unknown
- 1998-11-18 DZ DZ980265A patent/DZ2655A1/xx active
- 1998-11-18 CO CO98067902A patent/CO4771153A1/es unknown
- 1998-11-18 TN TNTNSN98210A patent/TNSN98210A1/fr unknown
- 1998-11-19 AP APAP/P/1998/001402A patent/AP909A/en active
2000
- 2000-04-26 IS IS5470A patent/IS2202B/is unknown
- 2000-05-12 OA OA1200000138A patent/OA11380A/en unknown
- 2000-05-15 BG BG104437A patent/BG63969B1/bg unknown
- 2000-05-18 NO NO20002544A patent/NO20002544L/no not_active Application Discontinuation
- 2000-05-18 KR KR10-2000-7005431A patent/KR100366902B1/ko not_active Expired - Fee Related
- 2000-05-18 PL PL98340642A patent/PL193484B1/pl unknown
2002
- 2002-06-18 JP JP2002177452A patent/JP2003040777A/ja active Pending
2003
- 2003-04-21 US US10/419,425 patent/US20030208079A1/en not_active Abandoned
2004
- 2004-07-07 NO NO20042879A patent/NO20042879L/no not_active Application Discontinuation
- 2004-11-18 US US10/991,977 patent/US20050171354A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2003040777A (ja)	2003-02-13
CO4771153A1 (es)	1999-04-30
NO20002544L (no)	2000-07-17
SK283460B6 (sk)	2003-08-05
KR100366902B1 (ko)	2003-01-09
HUP0101112A2 (hu)	2002-05-29
CN1279681A (zh)	2001-01-10
EA002621B1 (ru)	2002-06-27
AP909A (en)	2000-12-04
PL340642A1 (en)	2001-02-12
WO1999025714A1 (en)	1999-05-27
MA26567A1 (fr)	2004-12-20
AR016422A1 (es)	2001-07-04
TNSN98210A1 (fr)	2005-03-15
HK1033313A1 (en)	2001-08-24
DK1032571T3 (da)	2002-07-15
NZ503912A (en)	2002-09-27
HRP20000313A2 (en)	2000-12-31
PE20000021A1 (es)	2000-02-25
US20050171354A1 (en)	2005-08-04
DE69806045D1 (en)	2002-07-18
ES2177058T3 (es)	2002-12-01
YU29400A (sh)	2003-02-28
BG63969B1 (bg)	2003-08-29
PA8463001A1 (es)	2000-09-29
AU734218B2 (en)	2001-06-07
CZ297315B6 (cs)	2006-11-15
TR200001463T2 (tr)	2000-12-21
BG104437A (en)	2001-02-28
EP1032571A1 (en)	2000-09-06
HUP0101112A3 (en)	2002-06-28
AU9454998A (en)	1999-06-07
PL193484B1 (pl)	2007-02-28
EA200000432A1 (ru)	2000-12-25
AP9801402A0 (en)	1998-12-31
IS5470A (is)	2000-04-26
EP1032571B1 (en)	2002-06-12
MY120558A (en)	2005-11-30
JP3394239B2 (ja)	2003-04-07
JP2001523680A (ja)	2001-11-27
IL135631A0 (en)	2001-05-20
CA2310627C (en)	2005-08-09
RS49792B (sr)	2008-06-05
ATE219078T1 (de)	2002-06-15
DE69806045T2 (de)	2002-11-14
TW426667B (en)	2001-03-21
UA59417C2 (uk)	2003-09-15
CZ20001834A3 (cs)	2001-07-11
NO20002544D0 (no)	2000-05-18
OA11380A (en)	2004-01-27
DZ2655A1 (fr)	2003-03-22
CA2310627A1 (en)	1999-05-27
SK7232000A3 (en)	2001-09-11
CN1173974C (zh)	2004-11-03
PT1032571E (pt)	2002-09-30
IS2202B (is)	2007-02-15
US20030208079A1 (en)	2003-11-06
ID24240A (id)	2000-07-13
HRP20000313B1 (en)	2002-04-30

Legal Events

Date	Code	Title	Description
2009-05-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK1032571T3 (da)	2002-07-15	Cykliske peridinylaminomethyl-triflourmethyl-ether-forbindelser som substans P-antagonister
DE69905038D1 (de)	2003-02-27	Cyclische boroprolinverbindungen
DK1218359T3 (da)	2004-10-18	Piperazinforbindelser som tachykininantagonister
NO20003930L (no)	2000-10-04	Sammensetninger som inneholder organiske forbindelser
EE200000044A (et)	2000-10-16	Uued ühendid
DK0942901T3 (da)	2003-07-07	Cycliske iminer som pesticider
IS5393A (is)	2000-03-02	Ný froðumyndandi lyfjablanda
NO20012948L (no)	2001-06-15	Hydroksydifenylureasulfonamider som IL-8 reseptor antagonister
NO971137D0 (no)	1997-03-12	Dimetyl-(3-aryl-but-3-enyl)-aminforbindelse som farmasöytiske forbindelser
FI4209U1 (fi)	1999-11-10	Uusia yhdisteitä
DK0975623T3 (da)	2002-10-14	Indazolamidforbindelser som sertoninerge midler
FI974342A0 (fi)	1997-11-26	Foerfarande foer fakturering av tjaenster och produkter, som koepes i ett datanaet
DK1027342T3 (da)	2004-09-13	Cyclopentenderivater som motilinreceptorantagonister
DK0964863T3 (da)	2003-08-04	Oxazolidinoner som 5-HT2A-antagonister
NO20006227L (no)	2001-02-08	Tetrahydroquiolinderivater som glycin antagonister
BR9804301B1 (pt)	2008-11-18	compostos espirocÍclicos.
NO995782D0 (no)	1999-11-25	Kvarternaere ammoniumforbindelser som tachykinin-antagonister
DK1261588T3 (da)	2005-02-14	Imidazolforbindelser som alfa2-adrenoceptorantagonister
NO20002575D0 (no)	2000-05-19	Substituerte oksimer som neurokininantagonister
DE60006327D1 (de)	2003-12-11	Ethergruppen enthaltende Siloxy-Verbindungen
IL144466A0 (en)	2002-05-23	Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
SI1032571T1 (en)	2002-10-31	Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
ZA9810544B (en)	2000-05-18	Piperidinylaminomethyl Trifluoromethyl cyclic ether compounds as substance P antagonists.
FI974550A0 (fi)	1997-12-18	Styrsystem foer en soekmaskin, som anvaends i samband med ett data- eller telekommunikationsnaet
DK0994876T3 (da)	2004-12-13	Kvaternære ammoniumforbindelser som tachykinin-antagonister